Table 1.
Relationship between the level of OPN3 expression and clinical features in patients with LUAD
OPN3 level | ||||
---|---|---|---|---|
Low (n = 64) | High (n = 50) | χ2 | P‐value | |
Gender | 0.162 | 0.687 | ||
Male | 36 | 30 | ||
Female | 28 | 20 | ||
Age (year) | 2.019 | 0.155 | ||
<65 | 38 | 23 | ||
≥65 | 26 | 27 | ||
pT | 0.347 | 0.556 | ||
T1–T2 | 51 | 42 | ||
T3–T4 | 13 | 8 | ||
pN | 5.344 | 0.021* | ||
N0 | 50 | 29 | ||
N1–N2 | 14 | 21 | ||
pTNM | 3.577 | 0.059 | ||
I | 42 | 24 | ||
II–III | 22 | 26 |
P < 0.05 (Chi‐square tests).